
New research indicates that menopause acts as a specific vulnerability window for Alzheimer's disease in women who carry genetic risk factors. Simultaneously, biological sex appears to dictate how immune systems respond to chronic pain conditions like fibromyalgia and gut inflammation.
These findings justify moving away from one-size-fits-all treatments toward therapies tailored to individual hormonal and genetic profiles. However, the data currently rely on mouse models and early observational data, so the direct clinical application to human patients remains unproven.
more: https://www.sciencedaily.com/releases/2026/11/261115085535.htm
my other side: ivo.blogspot.com
Leave a Reply